Growth Metrics

Bioadaptives (BDPT) Free Cash Flow (2016 - 2025)

Bioadaptives' Free Cash Flow history spans 7 years, with the latest figure at -$155828.0 for Q4 2025.

  • On a quarterly basis, Free Cash Flow fell 54.99% to -$155828.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$516025.0, a 106.81% decrease, with the full-year FY2025 number at -$534025.0, down 114.02% from a year prior.
  • Free Cash Flow hit -$155828.0 in Q4 2025 for Bioadaptives, down from -$151309.0 in the prior quarter.
  • Over the last five years, Free Cash Flow for BDPT hit a ceiling of -$19461.0 in Q1 2023 and a floor of -$155828.0 in Q4 2025.
  • Historically, Free Cash Flow has averaged -$68761.2 across 5 years, with a median of -$58614.0 in 2021.
  • Biggest five-year swings in Free Cash Flow: tumbled 258.98% in 2021 and later skyrocketed 68.18% in 2023.
  • Tracing BDPT's Free Cash Flow over 5 years: stood at -$35403.0 in 2021, then increased by 22.31% to -$27504.0 in 2022, then crashed by 231.94% to -$91296.0 in 2023, then fell by 10.12% to -$100538.0 in 2024, then tumbled by 54.99% to -$155828.0 in 2025.
  • Business Quant data shows Free Cash Flow for BDPT at -$155828.0 in Q4 2025, -$151309.0 in Q3 2025, and -$110982.0 in Q2 2025.